Patrick J. Gannon, Ph.D.
|Pharmacology||University of Pennsylvania, Philadelphia, PA, United States|
Area:Molecular mechanisms underlying neuronal loss in neurodegenerative disorders
Mean distance: 19.15 (cluster 32)
ParentsSign in to add mentor
ChildrenSign in to add trainee
CollaboratorsSign in to add collaborator
BETA: Related publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
|Bond S, Lopez-Lloreda C, Gannon PJ, et al. (2020) The Integrated Stress Response and Phosphorylated Eukaryotic Initiation Factor 2α in Neurodegeneration. Journal of Neuropathology and Experimental Neurology|
|Stern AL, Ghura S, Gannon PJ, et al. (2018) BACE1 mediates HIV-associated and excitotoxic neuronal damage through an APP-dependent mechanism. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience|
|Gannon PJ, Akay-Espinoza C, Yee AC, et al. (2017) HIV Protease Inhibitors Alter Amyloid Precursor Protein Processing via β-Site Amyloid Precursor Protein Cleaving Enzyme-1 Translational Up-Regulation. The American Journal of Pathology. 187: 91-109|
|Jensen BK, Monnerie H, Mannell MV, et al. (2015) Altered Oligodendrocyte Maturation and Myelin Maintenance: The Role of Antiretrovirals in HIV-Associated Neurocognitive Disorders. Journal of Neuropathology and Experimental Neurology. 74: 1093-118|
|Akay C, Cooper M, Odeleye A, et al. (2014) Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system. Journal of Neurovirology. 20: 39-53|
|Gannon P, Khan MZ, Kolson DL. (2011) Current understanding of HIV-associated neurocognitive disorders pathogenesis. Current Opinion in Neurology. 24: 275-83|